Furthermore, DNases I and PAD4 inhibitors, which are key players in inhibiting NETs, have exhibited anti-inflammatory effects in conditions such as NETs-related kidney injury and acute respiratory distress syndrome (140, 141). This evidence concerns the gene DNASE1 and acute respiratory distress syndrome.